Supplementary announcement for 2019 Annual General Meeting

Announcement for the company to issue ordinary shares through rights offering and bank designated for collection and deposition
April 18, 2019
Supplementary announcement for the company to issue ordinary shares through rights offering
April 22, 2019
  1. Date of the board of directors resolution: Apr 19, 2019
  2. Date for convening the shareholders’ meeting: Jun 27, 2019
  3. Location for convening the shareholders’ meeting: Masterlink Securities Education and Training Center (11F., No.97, Sec. 2, Dunhua S. Rd., Da’ an Dist., Taipei City, Taiwan)
  4. Cause or subjects for convening the meeting (1)Report Items:
    <1> 2018 Business Report
    <2> 2017 Audit Committee’s Review Report
    <3> Comprehensive business initiatives
    <4> Status of treasury stocks
    <5> Amendment to “Management of Operation of Board Meeting” (New)
  5. Cause or subjects for convening the meeting (2)Matters for Ratification:
    <1> 2017 Settlement Statements
    <2> 2017 Deficit Compensation
  6. Cause or subjects for convening the meeting (3)Matters for Discussion:
    <1> Amendment of company’s articles of incorporation
    <2> Amendment of company’s acquisition and disposal of major assets policy
    <3> Amendment to “Management of Loans to Others” (New)
    <4> Amendment to “Management of Endorsement and Guarantees” (New)
  7. Cause or subjects for convening the meeting (4)Elections:
    <1> Election of the 6th board of directors
  8. Cause or subjects for convening the meeting (5)Other Proposals:
    <1> Lifting the restrictions on the new board of directors’ non-competition
  9. Cause or subjects for convening the meeting (6)Extemporary Motions:None
  10. Book closure starting date: Apr 29, 2019
  11. Book closure ending date: Jun 27, 2019
  12. Any other matters that need to be specified:
    Pursuant to Article 172-1 of the Company Law, the Annual General Meeting will accept shareholders’ proposals from Apr 19, 2019 to Apr 29, 2019. Shareholders holding more than 1% of shares should deliver proposal with applicable contact information before 5:00pm on Apr 29, 2019 for the board of directors to review and respond (Please note the Annual General Meeting on the envelope and send it by priority mail). Overdue will not be accepted.
    Proposal receiving office is the Financial Department of OBI Pharma Inc. (Address: 7th Floor, No. 369, Section 7, Zhongxiao East Road, Nangang District, Taipei, Tel: 02-27866589, ext. 115/157). The shareholders will be able to exercise their voting rights electronically from May 28, 2019 to Jun 24, 2019. The electronic voting system is managed by Taiwan Depository and Clearing Corporation at https://www.stockvote.com.tw